Srirupa is a cell biologist passionate about exploring diverse cell biology platforms to enable drug discovery. She received her Ph.D. in toxicology from UC Denver, and completed her postdoctoral research in Jay Debnath’s lab in UCSF, where she investigated the role of autophagy in cancer metabolism. Before joining Interline she was a researcher at Genentech, where she designed cell therapy strategies for preclinical models of solid tumors. Previously, Srirupta was also a research scientist in the immunooncology antibody discovery group of Bayer Healthcare.
Outside of work, Srirupa enjoys reading, cooking and spending time outdoors with family.